Mahathir Bayena

GenusPlus Group's (ASX:GNP) revenue went up to $535.4 million for the H1 FY26, representing an 61% increase in the prior-year period.

Pharmx Technologies (ASX:PHX) entered into a binding, multi-year strategic alliance with Sigma Healthcare (ASX:SIG).

Minerals 260 (ASX:MI6) announced a $220 million strategic funding agreement with Franco-Nevada Corporation to accelerate the development of its Bullabulling Gold Project.

OFX Group (ASX:OFX) appointed James Georgeson as its new CFO, effective Feb. 23.

Telefonica Brasil (NYSE:VIV), operating under the Vivo brand, reported fourth-quarter earnings that significantly outpaced analyst projections, driven by a strategic shift toward premium postpaid and fiber-optic services.

Largo (NASDAQ:LGO) has terminated its previously announced agreement to sell 4.5 million tonnes of iron ore calcine, a move that comes as the company pivots to address shifting U.S. trade policies and a surge in vanadium prices.

Enhabit (NYSE:EHAB), a national provider of home health and hospice services, announced Monday that it has entered into a definitive agreement to be acquired by Kinderhook Industries.

ImmunityBio (NASDAQ:IBRX), the California-based immunotherapy leader, reported explosive 2025 financial results on Monday, signaling its successful transition into a high-growth commercial powerhouse.

CN Energy Group (NASDAQ:CNEY), a manufacturer of activated carbon and biomass energy, announced Monday it has signed a definitive Share Purchase Agreement to acquire 100% of Blessing Logistics for $2 million.

Novo Nordisk (NYSE:NVO) shares tumbled Monday morning after the Danish drugmaker announced that its highly anticipated obesity treatment, CagriSema, failed to achieve non-inferiority against Eli Lilly’s (NYSE:LLY) blockbuster tirzepatide in a head-to-head Phase 3 trial.